NCT07355114

Brief Summary

The goal of this observational prospective cohort study is to evaluate the feasibility, safety, and postoperative outcomes of robotic-assisted unilateral native nephrectomy using the Medtronic Hugo™ RAS system compared with the open surgical approach in patients with autosomal dominant polycystic kidney disease (ADPKD) The main question(s) it aims to answer are: Is robotic-assisted unilateral nephrectomy with the Hugo™ RAS system feasible and safe in patients with ADPKD? Does robotic-assisted nephrectomy provide comparable or improved postoperative outcomes (e.g., complications, transfusion rates, length of hospital stay) compared with open nephrectomy? Researchers will compare robotic-assisted unilateral nephrectomy (Hugo™ RAS) with open unilateral nephrectomy to see if the robotic approach results in similar morbidity with shorter hospital stay, despite longer operative times. Participants are adult patients with ADPKD undergoing unilateral native nephrectomy at a single tertiary transplant center, most of whom have end-stage renal disease and are candidates for or recipients of kidney transplantation. Both male and female patients were included; patients undergoing bilateral nephrectomy were excluded.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for all trials

Timeline
20mo left

Started Jan 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2023Jan 2028

Study Start

First participant enrolled

January 1, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 16, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Expected
Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

2.7 years

First QC Date

December 16, 2025

Last Update Submit

January 12, 2026

Conditions

Keywords

ADPKD

Outcome Measures

Primary Outcomes (1)

  • Mortality by 90 day

    Mortality by 90 day

    By 90 days

Secondary Outcomes (1)

  • Postoperative complications

    By 90 days

Other Outcomes (3)

  • Feasibility and safety of robotic-assisted native radical nephrectomy with Hugo RAS ™ in patients with ADPKD

    Preoperative outcome measure: recorded at baseline Perioperative outcomes measure: perioperative/periprocedural Postoperative outcomes: up to 90 days after surgery. Follow up: through study completion

  • Haemoglobin drop

    Day 1

  • Operative time

    Perioperative/Periprocedural

Study Arms (2)

Open nephrectomy

Unilateral Nephrectomy for ADPKD

Robotic Nephrectomy

Unilateral Robotic nephrectomy for ADPKD with Hugo RAS System

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult Patients who underwent unilateral nephrectomy for ADPKD (Robotic with HUGO RAS System or open)

You may qualify if:

  • Adult Patients who underwent unilateral nephrectomy for ADPKD

You may not qualify if:

  • Patients who underwent bilateral nephrectomy for ADPKD were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCSS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bo, 40138, Italy

Location

MeSH Terms

Conditions

Polycystic Kidney, Autosomal Dominant

Condition Hierarchy (Ancestors)

Polycystic Kidney DiseasesKidney Diseases, CysticKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCiliopathiesGenetic Diseases, Inborn

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Unit ''Chirurgia addominale nell'insufficienza d'organo terminale e nei pazienti con trapianto d'organo''

Study Record Dates

First Submitted

December 16, 2025

First Posted

January 21, 2026

Study Start

January 1, 2023

Primary Completion

August 30, 2025

Study Completion (Estimated)

January 1, 2028

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations